Browsing Tag
Artrya Limited
1 post
Artrya (ASX: AYA) shares rise 3.3% as A$74m cash backs US Salix commercial rollout
Artrya has moved from clinical development into early United States commercialisation, with three health-system customers and its first Salix revenues now established. The company enters FY27 with A$74 million of cash and no debt, but FY26 statutory revenue remained only A$28,000 while operating investment drove the annual loss materially higher.